Suzhou Reconciled Depreciation from 2010 to 2025
| 688137 Stock | 32.12 0.28 0.86% |
Reconciled Depreciation | First Reported 2010-12-31 | Previous Quarter 25.9 M | Current Value 14.8 M | Quarterly Volatility 8.8 M |
Check Suzhou Novoprotein financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Suzhou Novoprotein's main balance sheet or income statement drivers, such as Net Interest Income of 32.4 M, Interest Income of 36.8 M or Interest Expense of 2.9 M, as well as many indicators such as . Suzhou financial statements analysis is a perfect complement when working with Suzhou Novoprotein Valuation or Volatility modules.
Suzhou | Reconciled Depreciation |
Currently Active Assets on Macroaxis
Other Information on Investing in Suzhou Stock
Suzhou Novoprotein financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Novoprotein security.